- Joined
- Sep 6, 2008
- Messages
- 4,186
I was looking at some research on the biological mechanism of hypertrophy and AR signaling and when reading this paper I came across the following:
"Androgens increase Notch in SM, which further increases Notch signaling (22). Conversely, the synthetic androgen analog Nandrolone Decanoate (ND) has been observed to reduce Notch activity while increasing Numb activity, highlighting the discrepancies of androgens on target outcomes "
Some of you know Nandrolone is my favorite compound for many reasons, so I wanted to dig a bit. Admittedly I am not an expert here, so I turned to ChatGPT to break it down for me.
I didn't realize that ND works on the AR in a fundamentally different manner than testosterone, working backwards in some ways. I'm sure there is much more to learn here, but I wanted to share this initial find. Perhaps some of you like @Swifto know this stuff, but it is new information for me.
It modulates different co-regulators and downstream pathways, even though it binds the same receptor.
Let’s unpack it properly.
Notch signalling in skeletal muscle is essential for:
Numb is a natural inhibitor of Notch.
Healthy muscle growth usually shows:
So Notch vs Numb balance = growth vs differentiation window.
Multiple studies show that physiologic and supraphysiologic androgens:
This fits the normal muscle-building model:
This is the unusual result.
Several studies (e.g., Sato et al., Serra et al.) show that nandrolone does the opposite:
This is not “bad,” but it is different. It suggests ND pushes the system toward:
This is why ND is useful in wasting disorders — it promotes direct tissue anabolism even without intense stem cell cycling.
The key insight:
The androgen receptor’s gene transcription depends heavily on:
ND sits in the AR binding pocket differently than testosterone:
This is well established in the SARMs literature:
Different ligands → different AR–cofactor interactomes → different transcriptional outcomes.
So ND is not simply a weaker testosterone.
It is a selective androgen receptor modulator (SARM-like).
This explains the Notch/Numb discrepancy:
Favors co-activators that:
Favors co-regulators that:
This divergence is known as ligand-specific AR signaling (LSS).
ND shows:
This profile makes ND ideal for:
Because stem cell activation (Notch-high states) is inflammation-sensitive and slower.
ND bypasses some of this and directly pushes muscle repair.
It has unique downstream effects.
Because Notch is lower and Numb is higher.
This is why people often say:
Because:
"Androgens increase Notch in SM, which further increases Notch signaling (22). Conversely, the synthetic androgen analog Nandrolone Decanoate (ND) has been observed to reduce Notch activity while increasing Numb activity, highlighting the discrepancies of androgens on target outcomes "
Some of you know Nandrolone is my favorite compound for many reasons, so I wanted to dig a bit. Admittedly I am not an expert here, so I turned to ChatGPT to break it down for me.
I didn't realize that ND works on the AR in a fundamentally different manner than testosterone, working backwards in some ways. I'm sure there is much more to learn here, but I wanted to share this initial find. Perhaps some of you like @Swifto know this stuff, but it is new information for me.
Nandrolone is not identical to testosterone in AR signalling.
It modulates different co-regulators and downstream pathways, even though it binds the same receptor.
Let’s unpack it properly.
1. Background: Notch vs Numb in Muscle
Notch signalling in skeletal muscle is essential for:
- satellite cell activation
- early myogenic commitment
- regeneration
- maintaining the pool of quiescent stem cells
Numb is a natural inhibitor of Notch.
- ↑ Numb = ↓ Notch
- ↑ Numb pushes cells toward differentiation rather than maintaining stemness
Healthy muscle growth usually shows:
- a coordinated pulse of Notch
- later, increases in Numb as cells differentiate
So Notch vs Numb balance = growth vs differentiation window.
2. Testosterone/DHT → ↑ Notch, ↓ Numb
Multiple studies show that physiologic and supraphysiologic androgens:
- increase Notch-1 and Notch-2 mRNA
- increase Jagged ligands
- suppress Numb
- promote satellite cell proliferation → early hypertrophic environment
This fits the normal muscle-building model:
Testosterone → more Notch → more satellite cell activation → more regenerative potential.
3. Nandrolone → ↓ Notch, ↑ Numb
This is the unusual result.
Several studies (e.g., Sato et al., Serra et al.) show that nandrolone does the opposite:
- ↓ Notch signaling
- ↑ Numb
- ↑ myogenic differentiation rather than stem cell expansion
- A shift toward later-stage myotube formation
This is not “bad,” but it is different. It suggests ND pushes the system toward:
More rapid satellite cell differentiation → less maintenance of the stem cell pool → potentially less regenerative cycling long-term.
This is why ND is useful in wasting disorders — it promotes direct tissue anabolism even without intense stem cell cycling.
4. The Mechanistic Reason: AR Selective Co-Regulator Recruitment
The key insight:
Nandrolone-bound AR recruits a different co-regulator set than testosterone-bound AR.
The androgen receptor’s gene transcription depends heavily on:
- which co-activators bind (SRC-1, p300, CBP, TIF2, etc.)
- which co-repressors bind (NCoR, SMRT)
- DNA response element context
- tissue-specific factors
ND sits in the AR binding pocket differently than testosterone:
- The A-ring on ND is altered (19-nor modification).
- ND induces a different AR conformational change.
- That conformation changes which co-regulators can dock.
This is well established in the SARMs literature:
Different ligands → different AR–cofactor interactomes → different transcriptional outcomes.
So ND is not simply a weaker testosterone.
It is a selective androgen receptor modulator (SARM-like).
This explains the Notch/Numb discrepancy:
Testosterone/DHT-bound AR
Favors co-activators that:
- upregulate Notch
- maintain early-stage proliferation pathways
- suppress Numb
Nandrolone-bound AR
Favors co-regulators that:
- suppress Notch pathway targets
- increase Numb
- promote differentiation over proliferation
This divergence is known as ligand-specific AR signaling (LSS).
5. Why ND Would Evolve This Behavior Biologically
ND shows:
- stronger anabolic potency
- weaker androgenic potency
- less AR-driven stem cell cycling
- more direct transcription of growth/differentiation genes
This profile makes ND ideal for:
- muscle wasting
- trauma
- cachexia
- elderly patients
Because stem cell activation (Notch-high states) is inflammation-sensitive and slower.
ND bypasses some of this and directly pushes muscle repair.
6. What This Means for Bodybuilders
1. ND is not a “testosterone equivalent.”
It has unique downstream effects.
2. ND might blunt satellite cell pool expansion over long cycles.
Because Notch is lower and Numb is higher.
3. ND encourages more immediate differentiation (myotube formation).
This is why people often say:
- “Nandrolone feels like it repairs joints.”
- “I heal on deca.”
4. ND stacked with testosterone restores the normal Notch profile.
Because:
- Testosterone → ↑ Notch
- ND → ↑ differentiation
This theoretically gives a “best of both worlds” effect: - test activates satellite cells
- ND helps mature and differentiate them
This is precisely how many bodybuilders run it.
7. One-sentence summary
Testosterone and DHT increase Notch signaling to expand satellite cells, but nandrolone changes AR co-regulator recruitment and instead increases Numb while suppressing Notch, driving satellite cells toward differentiation rather than proliferation.









































































